CureVac N.V.

NASDAQ: CVAC · Real-Time Price · USD
5.49
-0.02 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
5.55
1.18%
After-hours: Aug 15, 2025, 07:35 PM EDT

CureVac Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
893K 14.47M 493.9M 14.44M 12.37M 21.99M 16.48M 7.58M 7.13M 11.69M 11.21M 20.15M 24.37M 41.23M 29.34M 22.39M 10.03M
Cost of Revenue
875K 1.49M 21.93M 40.72M 41.69M 59.76M 24.28M 25.85M 20.64M 80M 24.08M 42.68M 37.23M 70.02M 115.02M 37.4M 15.76M
Gross Profit
18K 12.98M 471.97M -26.29M -29.32M -37.78M -7.8M -18.27M -13.51M -68.31M -12.87M -22.54M -12.86M -28.79M -85.68M -15M -5.73M
Operating Income
-54.73M -43.76M 368.38M -73.62M -73.32M -90.4M -54.04M -71.8M -60.35M -121.51M -52.38M -60.3M -15.27M -5.51M -143.09M -147.82M -115.83M
Interest Income
3.4M 3.72M 2.33M 2.53M 3.77M n/a 9.45M 6.2M 3.89M n/a 5.28M 3.32M 2.02M 1.27M 1.53M 342K 6.95M
Pretax Income
-51.66M -38.56M 370.57M -71.24M -69.89M -84.27M -48.67M -67.39M -57.42M -128.75M -47.65M -57.57M -15.19M -4.56M -143.51M -152.19M -112.23M
Net Income
-52.08M -32.76M 338.04M -72.54M -70.55M -84.43M -48.68M -67.41M -57.42M -128.78M -47.57M -57.58M -15.09M -1.94M -144.02M -152.06M -113.7M
Selling & General & Admin
17.46M 18.55M 14.24M 13.45M 16.8M 21.68M 15.98M 19.07M 19.7M 23.66M 22.08M 23.07M 20.6M 14.61M 22.66M 31.78M 19.9M
Research & Development
37.59M 44.14M 49.98M 31.09M 27.82M 29.37M 27.25M 30.87M 24.25M 27.62M 12.51M 11.64M 10.79M 531.18M 48.46M 131.28M 104.99M
Other Expenses
n/a -3.73M 39.38M 2.79M n/a n/a n/a n/a 3.2M 2.39M 4.92M 3.98M -28.98M -569.07M -13.71M -30.24M -14.78M
Operating Expenses
54.74M 56.74M 103.59M 47.33M 44.92M 52.63M 46.71M 53.7M 47.16M 53.67M 39.51M 38.68M 2.41M -23.28M 57.41M 132.82M 110.1M
Interest Expense
333K -636K 141K 155K 340K n/a 4.08M 1.78M 951K 8.11M 542K 593K 1.94M 323K 1.95M 4.71M 3.35M
Selling & Marketing Expenses
963K 1.25M 174K 75K 105K 82K 145K 88K 108K 97K 93K -44K 271K 511K 203K 552K 477K
Cost & Expenses
55.62M 58.23M 125.52M 88.06M 86.61M 112.39M 70.99M 79.56M 67.79M 133.67M 63.59M 81.36M 39.64M 46.74M 172.43M 170.22M 125.86M
Income Tax Expense
429K -5.8M 32.53M 1.3M 666K 160.77K 6K 26K 1K 34K -78K 14K -96K -2.62M 512K -137K 1.47M
Shares Outstanding (Basic)
225.15M 224.34M 224.31M 224.31M 224.29M 223.99M 223.91M 223.88M 211.44M 195M 184.09M 184.09M 184.09M 180.46M 180.46M 180.46M 184.09M
Shares Outstanding (Diluted)
225.15M 224.79M 224.31M 224.31M 224.29M 223.99M 223.91M 223.88M 211.44M 195M 184.09M 184.09M 184.09M 180.46M 180.46M 180.46M 187.03M
EPS (Basic)
-0.23 -0.15 1.51 -0.32 -0.31 -0.38 -0.22 -0.3 -0.27 -0.66 -0.26 -0.31 -0.08 -0.01 -0.8 -0.84 -0.62
EPS (Diluted)
-0.23 -0.15 1.51 -0.32 -0.31 -0.38 -0.22 -0.3 -0.27 -0.66 -0.26 -0.31 -0.08 -0.01 -0.8 -0.84 -0.61
EBITDA
-46.74M -34.89M 375.23M -65.96M -72.22M -81.32M -38.68M -59.97M -56.36M -125.91M -40.41M -49.4M -4.17M -21.2M -136.84M -144.08M -105.66M
EBIT
-51.32M -39.2M 370.71M -71.09M -69.55M -90.81M -44.59M -65.6M -56.47M -128.12M -47.1M -56.98M -13.25M -4.24M -141.56M -147.48M -108.88M
Depreciation & Amortization
4.58M 4.3M 4.51M 5.13M 5.13M 9.08M 6.28M 5.79M 5.94M 3.37M 6.72M 7.55M 9.26M 23M 4.72M 3.4M 3.3M